The neuronal selective nitric oxide inhibitor AR-R 17477, blocks some effects of phencyclidine, while having no observable behavioural effects when given alone
C. Johansson et al., The neuronal selective nitric oxide inhibitor AR-R 17477, blocks some effects of phencyclidine, while having no observable behavioural effects when given alone, PHARM TOX, 84(5), 1999, pp. 226-233
We have previously shown that the non-specific nitric oxide synthase inhibi
tor L-NAME blocks the behavioural effects of phencyclidine, but not d-amphe
tamine. To characterise the specificity of these effects, we used the speci
fic neuronal nitric oxide synthase inhibitor AR-R 17477 in two rat models o
f psychosis: the prepulse inhibition of the acoustic startle response and l
ocomotor activity. In biochemical assays, AR-R 17477 was shown to be select
ive for the neuronal nitric oxide synthase isoform. Test drugs were given s
ubcutaneously. AR-R 17477 (0.5, 1 and 5 mg/kg) antagonised phencyclidine-in
duced hyperlocomotion, while higher doses (10 and 20 mg/kg) were less effic
aceous. AR-R 17477 (1 mg/kg) antagonised phencyclidine-induced deficit in p
repulse inhibition of the acoustic startle response, while a higher dose (1
5 mg/kg) was less active. AR-R 17477 did not affect startle amplitude or pr
epulse inhibition of the acoustic startle response, did not effect locomoti
on and did not induce any changes in gross behaviour (sniffing, rearing, et
c.) as determined in a subjective observation study. AR-R 17477 (1 mg/kg) d
id not alter the effect of d-amphetamine in prepulse inhibition of the acou
stic startle response. Using radiotelemetry in rats, L-NAME (ID mg/kg subcu
taneously) increased blood pressure and decreased heart rate while AR-R 174
77 (10 mg/kg) did not have any significant effect on these parameters. The
results show that a neuronal nitric oxide synthase inhibitor antagonises th
e effects of phencyclidine on prepulse inhibition of the acoustic startle r
esponse and locomotor activity, without exhibiting significant behavioural
effects of its own and suggest that our earlier results with L-NAME depende
d upon an inhibition of neuronal nitric oxide synthase and not on an inhibi
tion of endothelial nitric oxide synthase or inducible nitric oxide synthas
e. The observed effects are unlikely to be related to an effect on cardiova
scular function.